CIQ is a positive allosteric modulator of NMDA receptor with high selectivity for the GluN2C/D subunits, and it can cross the blood-brain barrier. CIQ rescues working memory deficits induced by delayed matching-to-sample tasks, it reverses forelimb use asymmetry behavioral deficits caused by unilateral dopamine depletion. CIQ can be used in research related to schizophrenia and Parkinsons disease[1][2].
Molecular Weight:
467.94
Purity:
99.75
CAS Number:
[486427-17-2]
Formula:
C26H26ClNO5
Target:
iGluR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
